Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

SELL
$6.27 - $7.7 $123,669 - $151,874
-19,724 Reduced 46.75%
22,465 $142,000
Q1 2024

May 14, 2024

BUY
$5.47 - $11.38 $230,773 - $480,110
42,189 New
42,189 $282,000

Others Institutions Holding GRFS

About Grifols SA


  • Ticker GRFS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 678,910,976
  • Market Cap $5.33B
  • Description
  • Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...
More about GRFS
Track This Portfolio

Track Mint Tower Capital Management B.V. Portfolio

Follow Mint Tower Capital Management B.V. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mint Tower Capital Management B.V., based on Form 13F filings with the SEC.

News

Stay updated on Mint Tower Capital Management B.V. with notifications on news.